CDNA CareDx Inc

Price (delayed)

$77.71

Market cap

$4.05B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.29

Enterprise value

$3.75B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

The company's quick ratio has surged by 144% QoQ
The equity has soared by 70% from the previous quarter
The debt has grown by 15% since the previous quarter and by 5% year-on-year

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
52.05M
Market cap
$4.05B
Enterprise value
$3.75B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.54
Price to sales (P/S)
17.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.97
Earnings
Revenue
$221.21M
EBIT
-$14.85M
EBITDA
-$4.91M
Free cash flow
-$3.8M
Per share
EPS
-$0.29
Free cash flow per share
-$0.07
Book value per share
$9.1
Revenue per share
$4.32
TBVPS
$9.18
Balance sheet
Total assets
$541.22M
Total liabilities
$69.68M
Debt
$18.46M
Equity
$471.55M
Working capital
$392.97M
Liquidity
Debt to equity
0.04
Current ratio
9.59
Quick ratio
9.14
Net debt/EBITDA
59.32
Margins
EBITDA margin
-2.2%
Gross margin
67.3%
Net margin
-6.1%
Operating margin
-8%
Efficiency
Return on assets
-3.4%
Return on equity
-4.2%
Return on invested capital
-20.1%
Return on capital employed
-3%
Return on sales
-6.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
6.92%
1 week
-1.72%
1 month
8.49%
1 year
165.49%
YTD
7.26%
QTD
14.13%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$221.21M
Gross profit
$148.91M
Operating income
-$17.64M
Net income
-$13.58M
Gross margin
67.3%
Net margin
-6.1%
CDNA's gross profit has surged by 63% year-on-year and by 15% since the previous quarter
The revenue has soared by 59% YoY and by 15% QoQ
The net margin has surged by 58% year-on-year and by 37% since the previous quarter
CareDx's operating margin has soared by 55% YoY and by 32% from the previous quarter

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
8.54
P/S
17.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.97
CareDx's EPS has increased by 40% YoY and by 28% from the previous quarter
The equity has soared by 70% from the previous quarter
The stock's price to book (P/B) is 3% less than its 5-year quarterly average of 8.8 but 2.9% more than its last 4 quarters average of 8.3
The price to sales (P/S) is 128% more than the 5-year quarterly average of 7.9 and 31% more than the last 4 quarters average of 13.7
The revenue has soared by 59% YoY and by 15% QoQ

Efficiency

How efficient is CareDx business performance
The ROIC has soared by 86% YoY and by 47% QoQ
The ROE has soared by 80% YoY and by 49% from the previous quarter
CDNA's return on assets has surged by 75% year-on-year and by 44% since the previous quarter
CareDx's ROS has soared by 59% YoY and by 36% from the previous quarter

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
The company's quick ratio has surged by 144% QoQ
CDNA's current ratio has soared by 143% since the previous quarter
The debt is 96% smaller than the equity
CareDx's debt to equity has shrunk by 76% YoY and by 33% QoQ
The equity has soared by 70% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.